ENDOCYTE INC 4
4 · ENDOCYTE INC · Filed Feb 3, 2017
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Parker Katherine
VP of Human Resources
Transactions
- Award
Common Stock
2017-02-02+12,500→ 31,609 total - Award
Stock Option (right to buy)
2017-02-02+25,000→ 25,000 totalExercise: $2.16Exp: 2027-02-02→ Common Stock (25,000 underlying)
Holdings
- 1,200(indirect: By Trust)
Common Stock
- 1,200(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on February 2, 2018, in the form of one share of common stock for each restricted stock unit.
- [F2]Includes 631 and 870 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2016 and December 15, 2016, respectively.
- [F3]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 2, 2018.